

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 7.52054038 |
| 2 | postsynaptic membrane organization (GO:0001941) | 6.48370291 |
| 3 | presynaptic membrane assembly (GO:0097105) | 5.84845743 |
| 4 | presynaptic membrane organization (GO:0097090) | 5.22995386 |
| 5 | auditory behavior (GO:0031223) | 5.18335675 |
| 6 | startle response (GO:0001964) | 4.95266305 |
| 7 | regulation of pigment cell differentiation (GO:0050932) | 4.59647734 |
| 8 | mechanosensory behavior (GO:0007638) | 4.53240666 |
| 9 | facial nerve structural organization (GO:0021612) | 4.17268076 |
| 10 | developmental pigmentation (GO:0048066) | 4.14387149 |
| 11 | negative regulation of myotube differentiation (GO:0010832) | 4.01708504 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.98366504 |
| 13 | neuronal action potential propagation (GO:0019227) | 3.97136977 |
| 14 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.95389191 |
| 15 | fucose catabolic process (GO:0019317) | 3.89847797 |
| 16 | L-fucose metabolic process (GO:0042354) | 3.89847797 |
| 17 | L-fucose catabolic process (GO:0042355) | 3.89847797 |
| 18 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 3.85695047 |
| 19 | cranial nerve morphogenesis (GO:0021602) | 3.84578385 |
| 20 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.84212332 |
| 21 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.78835749 |
| 22 | neuron cell-cell adhesion (GO:0007158) | 3.76746945 |
| 23 | cranial nerve structural organization (GO:0021604) | 3.75972148 |
| 24 | indolalkylamine metabolic process (GO:0006586) | 3.71231121 |
| 25 | generation of neurons (GO:0048699) | 3.70604213 |
| 26 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.69542997 |
| 27 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.66940196 |
| 28 | response to auditory stimulus (GO:0010996) | 3.61271482 |
| 29 | negative regulation of granulocyte differentiation (GO:0030853) | 3.58846740 |
| 30 | central nervous system neuron axonogenesis (GO:0021955) | 3.57317896 |
| 31 | negative regulation of telomere maintenance (GO:0032205) | 3.56106339 |
| 32 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.51902319 |
| 33 | tongue development (GO:0043586) | 3.49797100 |
| 34 | protein localization to synapse (GO:0035418) | 3.48252382 |
| 35 | protein polyglutamylation (GO:0018095) | 3.43708639 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.43481006 |
| 37 | reflex (GO:0060004) | 3.41612896 |
| 38 | righting reflex (GO:0060013) | 3.40096282 |
| 39 | positive regulation of dendritic spine development (GO:0060999) | 3.35071382 |
| 40 | central nervous system myelination (GO:0022010) | 3.35000785 |
| 41 | axon ensheathment in central nervous system (GO:0032291) | 3.35000785 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.34672848 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.30549073 |
| 44 | regulation of timing of cell differentiation (GO:0048505) | 3.28744026 |
| 45 | indole-containing compound catabolic process (GO:0042436) | 3.27621422 |
| 46 | indolalkylamine catabolic process (GO:0046218) | 3.27621422 |
| 47 | tryptophan catabolic process (GO:0006569) | 3.27621422 |
| 48 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26275407 |
| 49 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.25316816 |
| 50 | synaptic transmission, glutamatergic (GO:0035249) | 3.24561768 |
| 51 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.23213174 |
| 52 | cell proliferation in forebrain (GO:0021846) | 3.22854255 |
| 53 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.22284503 |
| 54 | regulation of hippo signaling (GO:0035330) | 3.21913452 |
| 55 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 3.21755335 |
| 56 | protein complex biogenesis (GO:0070271) | 3.19492552 |
| 57 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.19391415 |
| 58 | NADH dehydrogenase complex assembly (GO:0010257) | 3.19391415 |
| 59 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.19391415 |
| 60 | spinal cord association neuron differentiation (GO:0021527) | 3.16034484 |
| 61 | parturition (GO:0007567) | 3.15196512 |
| 62 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.13365696 |
| 63 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.13043614 |
| 64 | sympathetic nervous system development (GO:0048485) | 3.12666616 |
| 65 | synaptic transmission, cholinergic (GO:0007271) | 3.11550861 |
| 66 | GPI anchor biosynthetic process (GO:0006506) | 3.08058574 |
| 67 | vocalization behavior (GO:0071625) | 3.07932226 |
| 68 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.06063058 |
| 69 | cytochrome complex assembly (GO:0017004) | 3.04903543 |
| 70 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.02690415 |
| 71 | detection of light stimulus involved in visual perception (GO:0050908) | 3.02041402 |
| 72 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.02041402 |
| 73 | indole-containing compound metabolic process (GO:0042430) | 3.01643719 |
| 74 | positive regulation of synapse assembly (GO:0051965) | 3.00154628 |
| 75 | regulation of respiratory system process (GO:0044065) | 3.00044698 |
| 76 | dendritic spine morphogenesis (GO:0060997) | 2.99000529 |
| 77 | response to pheromone (GO:0019236) | 2.98964043 |
| 78 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.98493172 |
| 79 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.98236979 |
| 80 | serotonin metabolic process (GO:0042428) | 2.98106354 |
| 81 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.97313546 |
| 82 | primary amino compound metabolic process (GO:1901160) | 2.95723778 |
| 83 | rRNA catabolic process (GO:0016075) | 2.94673201 |
| 84 | regulation of mesoderm development (GO:2000380) | 2.94591574 |
| 85 | mesonephros development (GO:0001823) | 2.93678659 |
| 86 | specification of organ identity (GO:0010092) | 2.90151119 |
| 87 | nonmotile primary cilium assembly (GO:0035058) | 2.89776958 |
| 88 | regulation of respiratory gaseous exchange (GO:0043576) | 2.89467166 |
| 89 | nucleobase catabolic process (GO:0046113) | 2.88936454 |
| 90 | gamma-aminobutyric acid transport (GO:0015812) | 2.87098352 |
| 91 | nephron tubule formation (GO:0072079) | 2.86948574 |
| 92 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.86508038 |
| 93 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.86364528 |
| 94 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.86131995 |
| 95 | C-terminal protein lipidation (GO:0006501) | 2.85510572 |
| 96 | DNA deamination (GO:0045006) | 2.85144777 |
| 97 | regulation of action potential (GO:0098900) | 2.84891762 |
| 98 | G-protein coupled receptor internalization (GO:0002031) | 2.83428894 |
| 99 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.82214112 |
| 100 | neurofilament cytoskeleton organization (GO:0060052) | 2.81717159 |
| 101 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.81696662 |
| 102 | piRNA metabolic process (GO:0034587) | 2.81529399 |
| 103 | regulation of development, heterochronic (GO:0040034) | 2.80634788 |
| 104 | neuron-neuron synaptic transmission (GO:0007270) | 2.79995000 |
| 105 | epithelial cilium movement (GO:0003351) | 2.79410365 |
| 106 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.79196691 |
| 107 | mannosylation (GO:0097502) | 2.79079565 |
| 108 | tryptophan metabolic process (GO:0006568) | 2.77960319 |
| 109 | cornea development in camera-type eye (GO:0061303) | 2.77879950 |
| 110 | sulfation (GO:0051923) | 2.77832608 |
| 111 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.76888946 |
| 112 | lymphoid progenitor cell differentiation (GO:0002320) | 2.75622456 |
| 113 | regulation of telomere maintenance (GO:0032204) | 2.74544595 |
| 114 | spinal cord development (GO:0021510) | 2.74389099 |
| 115 | respiratory chain complex IV assembly (GO:0008535) | 2.73781262 |
| 116 | myeloid leukocyte mediated immunity (GO:0002444) | 2.73627019 |
| 117 | positive regulation of fatty acid oxidation (GO:0046321) | 2.72300144 |
| 118 | protein heterotetramerization (GO:0051290) | 2.70139886 |
| 119 | GPI anchor metabolic process (GO:0006505) | 2.68456436 |
| 120 | C-terminal protein amino acid modification (GO:0018410) | 2.66923322 |
| 121 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.66454412 |
| 122 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.66144975 |
| 123 | positive regulation of membrane potential (GO:0045838) | 2.65674826 |
| 124 | mesenchymal to epithelial transition (GO:0060231) | 2.65115174 |
| 125 | viral genome replication (GO:0019079) | 2.65000948 |
| 126 | L-amino acid import (GO:0043092) | 2.64906100 |
| 127 | behavioral response to ethanol (GO:0048149) | 2.64832787 |
| 128 | cranial nerve development (GO:0021545) | 2.63961114 |
| 129 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.63759637 |
| 130 | androgen biosynthetic process (GO:0006702) | 2.62467371 |
| 131 | long-term memory (GO:0007616) | 2.61571216 |
| 132 | neuronal action potential (GO:0019228) | 2.61368899 |
| 133 | adult walking behavior (GO:0007628) | 2.59151175 |
| 134 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.58436768 |
| 135 | oxidative demethylation (GO:0070989) | 2.58284728 |
| 136 | synapse assembly (GO:0007416) | 2.57197561 |
| 137 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.56813496 |
| 138 | head development (GO:0060322) | 2.56602359 |
| 139 | innervation (GO:0060384) | 2.56116323 |
| 140 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.55552080 |
| 141 | DNA methylation involved in gamete generation (GO:0043046) | 2.55341178 |
| 142 | rhodopsin mediated signaling pathway (GO:0016056) | 2.55246542 |
| 143 | cochlea development (GO:0090102) | 2.53773948 |
| 144 | regulation of synapse assembly (GO:0051963) | 2.53768914 |
| 145 | protein-cofactor linkage (GO:0018065) | 2.53191367 |
| 146 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.52648044 |
| 147 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.52279767 |
| 148 | regulation of mitochondrial translation (GO:0070129) | 2.51295001 |
| 149 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.50728372 |
| 150 | short-term memory (GO:0007614) | 2.49812647 |
| 151 | cellular ketone body metabolic process (GO:0046950) | 2.49805643 |
| 152 | membrane depolarization during action potential (GO:0086010) | 2.49780104 |
| 153 | negative regulation of response to food (GO:0032096) | 2.49096394 |
| 154 | negative regulation of appetite (GO:0032099) | 2.49096394 |
| 155 | polyketide metabolic process (GO:0030638) | 2.48859509 |
| 156 | doxorubicin metabolic process (GO:0044598) | 2.48859509 |
| 157 | daunorubicin metabolic process (GO:0044597) | 2.48859509 |
| 158 | positive regulation of action potential (GO:0045760) | 2.48020335 |
| 159 | positive regulation of gastrulation (GO:2000543) | 2.47732835 |
| 160 | transmission of nerve impulse (GO:0019226) | 2.47626237 |
| 161 | DNA integration (GO:0015074) | 2.47390367 |
| 162 | protein localization to cilium (GO:0061512) | 2.47205486 |
| 163 | retinal ganglion cell axon guidance (GO:0031290) | 2.46775609 |
| 164 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.46376124 |
| 165 | neurogenesis (GO:0022008) | 2.45284052 |
| 166 | centriole assembly (GO:0098534) | 2.44948685 |
| 167 | kidney morphogenesis (GO:0060993) | 2.44804973 |
| 168 | urogenital system development (GO:0001655) | 2.44133670 |
| 169 | somite development (GO:0061053) | 2.43284130 |
| 170 | neuromuscular synaptic transmission (GO:0007274) | 2.42568053 |
| 171 | regulation of somitogenesis (GO:0014807) | 2.42430009 |
| 172 | amino acid import (GO:0043090) | 2.41240743 |
| 173 | regulation of cellular respiration (GO:0043457) | 2.41189996 |
| 174 | regulation of gene silencing by RNA (GO:0060966) | 2.40850157 |
| 175 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.40850157 |
| 176 | regulation of gene silencing by miRNA (GO:0060964) | 2.40850157 |
| 177 | auditory receptor cell stereocilium organization (GO:0060088) | 2.39937358 |
| 178 | peptidyl-histidine modification (GO:0018202) | 2.39752631 |
| 179 | spinal cord motor neuron differentiation (GO:0021522) | 2.37597187 |
| 180 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.37581575 |
| 181 | membrane repolarization during action potential (GO:0086011) | 2.36868838 |
| 182 | chaperone-mediated protein transport (GO:0072321) | 2.35108165 |
| 183 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.33523902 |
| 184 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.33480263 |
| 185 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.32787165 |
| 186 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.32787165 |
| 187 | axoneme assembly (GO:0035082) | 2.32350551 |
| 188 | action potential (GO:0001508) | 2.31684335 |
| 189 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.31335221 |
| 190 | regulation of microtubule-based movement (GO:0060632) | 2.30881864 |
| 191 | glycerophospholipid catabolic process (GO:0046475) | 2.29091323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 8.96007629 |
| 2 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.91100386 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72946412 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.25499066 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.25013154 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.82198224 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.54846073 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.46830078 |
| 9 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.45439798 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.38217274 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.29142061 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.26867225 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.26867225 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.22843563 |
| 15 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.14876446 |
| 16 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.13132716 |
| 17 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.08492865 |
| 18 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.07783550 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03895361 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03101301 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00110148 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.99700488 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94368344 |
| 24 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.92361999 |
| 25 | * IRF1_19129219_ChIP-ChIP_H3396_Human | 1.91825606 |
| 26 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.91111273 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.88915823 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.88795100 |
| 29 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.88614947 |
| 30 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.83937009 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83349729 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.82188203 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.79472494 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.78765082 |
| 35 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.76413220 |
| 36 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.75958608 |
| 37 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.73377007 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.71862292 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71402755 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.64105013 |
| 41 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.62569307 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62511814 |
| 43 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.60691159 |
| 44 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.57282564 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.51671145 |
| 46 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.51320232 |
| 47 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.50316629 |
| 48 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.49182473 |
| 49 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.45877522 |
| 50 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45776882 |
| 51 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44263677 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44052606 |
| 53 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.43513140 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.42470281 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.41960848 |
| 56 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.41886200 |
| 57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41876350 |
| 58 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.41201161 |
| 59 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.41201161 |
| 60 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.41201161 |
| 61 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40069807 |
| 62 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.39358594 |
| 63 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37281845 |
| 64 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.36895992 |
| 65 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.36669472 |
| 66 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.35976897 |
| 67 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.35354370 |
| 68 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.35292129 |
| 69 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.34961673 |
| 70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34948881 |
| 71 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.33666733 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.32002364 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.30155072 |
| 74 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29547934 |
| 75 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.28800531 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28375353 |
| 77 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27470978 |
| 78 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.27349961 |
| 79 | ERA_21632823_ChIP-Seq_H3396_Human | 1.25998971 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.24717972 |
| 81 | NCOR_22424771_ChIP-Seq_293T_Human | 1.24033758 |
| 82 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23736857 |
| 83 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23736857 |
| 84 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23506159 |
| 85 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23144307 |
| 86 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22449193 |
| 87 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22251103 |
| 88 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.22048400 |
| 89 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.20522552 |
| 90 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20018531 |
| 91 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.19673190 |
| 92 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.19278308 |
| 93 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17638526 |
| 94 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.15799164 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.15291504 |
| 96 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15179028 |
| 97 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15179028 |
| 98 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.14336672 |
| 99 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.12520570 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.12370166 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.12045962 |
| 102 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11882474 |
| 103 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.11810297 |
| 104 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.11406961 |
| 105 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11371201 |
| 106 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11371201 |
| 107 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.11204605 |
| 108 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.09253297 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09068129 |
| 110 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.08987038 |
| 111 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08158615 |
| 112 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.08094142 |
| 113 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07899252 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07644932 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.07633933 |
| 116 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.07119728 |
| 117 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05192795 |
| 118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.02841121 |
| 119 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02661739 |
| 120 | EWS_26573619_Chip-Seq_HEK293_Human | 1.01596656 |
| 121 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01235635 |
| 122 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00657163 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99694681 |
| 124 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.99211808 |
| 125 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96593408 |
| 126 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96289907 |
| 127 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96239407 |
| 128 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.96007770 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.95028368 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.93539924 |
| 131 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93073781 |
| 132 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92821041 |
| 133 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.92772892 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.92771191 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92414486 |
| 136 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92171064 |
| 137 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91101730 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88879674 |
| 139 | TCF4_23295773_ChIP-Seq_U87_Human | 0.88843332 |
| 140 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88593772 |
| 141 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.88578925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005409_darkened_coat_color | 5.03277640 |
| 2 | MP0003136_yellow_coat_color | 4.08911565 |
| 3 | MP0001188_hyperpigmentation | 4.06444069 |
| 4 | MP0006292_abnormal_olfactory_placode | 4.01866031 |
| 5 | MP0003880_abnormal_central_pattern | 3.95111236 |
| 6 | MP0009379_abnormal_foot_pigmentation | 3.45709949 |
| 7 | MP0000015_abnormal_ear_pigmentation | 2.73593979 |
| 8 | MP0004859_abnormal_synaptic_plasticity | 2.66345980 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.65952063 |
| 10 | MP0000566_synostosis | 2.56507898 |
| 11 | MP0004381_abnormal_hair_follicle | 2.50384522 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.29109035 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.27793274 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.15291906 |
| 15 | MP0003635_abnormal_synaptic_transmissio | 2.06941381 |
| 16 | MP0008877_abnormal_DNA_methylation | 2.02638856 |
| 17 | MP0001486_abnormal_startle_reflex | 1.99671116 |
| 18 | MP0002736_abnormal_nociception_after | 1.94926219 |
| 19 | MP0005171_absent_coat_pigmentation | 1.93127536 |
| 20 | MP0001986_abnormal_taste_sensitivity | 1.92369817 |
| 21 | MP0009745_abnormal_behavioral_response | 1.92115337 |
| 22 | MP0002102_abnormal_ear_morphology | 1.91947624 |
| 23 | MP0009046_muscle_twitch | 1.91038127 |
| 24 | MP0002653_abnormal_ependyma_morphology | 1.87056127 |
| 25 | MP0008872_abnormal_physiological_respon | 1.78657911 |
| 26 | MP0000778_abnormal_nervous_system | 1.78551787 |
| 27 | MP0008260_abnormal_autophagy | 1.78372156 |
| 28 | MP0004885_abnormal_endolymph | 1.73506769 |
| 29 | MP0002272_abnormal_nervous_system | 1.71628723 |
| 30 | MP0005075_abnormal_melanosome_morpholog | 1.68134027 |
| 31 | MP0003195_calcinosis | 1.66725113 |
| 32 | MP0002067_abnormal_sensory_capabilities | 1.62445782 |
| 33 | MP0001502_abnormal_circadian_rhythm | 1.59524716 |
| 34 | MP0002184_abnormal_innervation | 1.58819905 |
| 35 | MP0002095_abnormal_skin_pigmentation | 1.57194871 |
| 36 | MP0002277_abnormal_respiratory_mucosa | 1.57093536 |
| 37 | MP0002064_seizures | 1.54233116 |
| 38 | MP0000631_abnormal_neuroendocrine_gland | 1.51227409 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.50834604 |
| 40 | MP0004142_abnormal_muscle_tone | 1.49704615 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.49197259 |
| 42 | MP0002837_dystrophic_cardiac_calcinosis | 1.48422413 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.48396982 |
| 44 | MP0006072_abnormal_retinal_apoptosis | 1.46445663 |
| 45 | MP0002160_abnormal_reproductive_system | 1.46351834 |
| 46 | MP0002234_abnormal_pharynx_morphology | 1.45149669 |
| 47 | MP0004270_analgesia | 1.44456517 |
| 48 | MP0004043_abnormal_pH_regulation | 1.44371791 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.43249735 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.42093080 |
| 51 | MP0002734_abnormal_mechanical_nocicepti | 1.40653335 |
| 52 | MP0000427_abnormal_hair_cycle | 1.40097012 |
| 53 | MP0002063_abnormal_learning/memory/cond | 1.39979893 |
| 54 | MP0003938_abnormal_ear_development | 1.38278985 |
| 55 | MP0004742_abnormal_vestibular_system | 1.37716409 |
| 56 | MP0002735_abnormal_chemical_nociception | 1.34619839 |
| 57 | MP0003011_delayed_dark_adaptation | 1.33243922 |
| 58 | MP0003879_abnormal_hair_cell | 1.30873084 |
| 59 | MP0008875_abnormal_xenobiotic_pharmacok | 1.30801259 |
| 60 | MP0005253_abnormal_eye_physiology | 1.29504587 |
| 61 | MP0002928_abnormal_bile_duct | 1.29385733 |
| 62 | MP0005394_taste/olfaction_phenotype | 1.28345062 |
| 63 | MP0005499_abnormal_olfactory_system | 1.28345062 |
| 64 | MP0000026_abnormal_inner_ear | 1.27431268 |
| 65 | MP0001970_abnormal_pain_threshold | 1.24942266 |
| 66 | MP0003137_abnormal_impulse_conducting | 1.24511580 |
| 67 | MP0005389_reproductive_system_phenotype | 1.23208573 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.21980003 |
| 69 | MP0002751_abnormal_autonomic_nervous | 1.20751774 |
| 70 | MP0003724_increased_susceptibility_to | 1.18932298 |
| 71 | MP0000955_abnormal_spinal_cord | 1.17870068 |
| 72 | MP0003121_genomic_imprinting | 1.16459411 |
| 73 | MP0003283_abnormal_digestive_organ | 1.16447088 |
| 74 | MP0003646_muscle_fatigue | 1.16221479 |
| 75 | MP0002249_abnormal_larynx_morphology | 1.15940534 |
| 76 | MP0002876_abnormal_thyroid_physiology | 1.15836488 |
| 77 | MP0000049_abnormal_middle_ear | 1.15057366 |
| 78 | MP0005195_abnormal_posterior_eye | 1.14929845 |
| 79 | MP0004130_abnormal_muscle_cell | 1.14467774 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 1.13766793 |
| 81 | MP0002938_white_spotting | 1.11370310 |
| 82 | MP0003119_abnormal_digestive_system | 1.11245789 |
| 83 | MP0000613_abnormal_salivary_gland | 1.11169954 |
| 84 | MP0003890_abnormal_embryonic-extraembry | 1.11149138 |
| 85 | MP0000681_abnormal_thyroid_gland | 1.08220136 |
| 86 | MP0001963_abnormal_hearing_physiology | 1.07949462 |
| 87 | MP0002752_abnormal_somatic_nervous | 1.05343947 |
| 88 | MP0008569_lethality_at_weaning | 1.01633571 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.00864372 |
| 90 | MP0001984_abnormal_olfaction | 0.99807179 |
| 91 | MP0008058_abnormal_DNA_repair | 0.99416342 |
| 92 | MP0002733_abnormal_thermal_nociception | 0.99252366 |
| 93 | MP0000372_irregular_coat_pigmentation | 0.98297929 |
| 94 | MP0001919_abnormal_reproductive_system | 0.98097750 |
| 95 | MP0000538_abnormal_urinary_bladder | 0.97838462 |
| 96 | MP0004085_abnormal_heartbeat | 0.97646823 |
| 97 | MP0002177_abnormal_outer_ear | 0.97336579 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.97235435 |
| 99 | MP0002138_abnormal_hepatobiliary_system | 0.96391752 |
| 100 | MP0008057_abnormal_DNA_replication | 0.96170131 |
| 101 | MP0003787_abnormal_imprinting | 0.95333146 |
| 102 | MP0009697_abnormal_copulation | 0.94756160 |
| 103 | MP0002882_abnormal_neuron_morphology | 0.92817962 |
| 104 | MP0008995_early_reproductive_senescence | 0.92173556 |
| 105 | MP0002075_abnormal_coat/hair_pigmentati | 0.90921233 |
| 106 | MP0003878_abnormal_ear_physiology | 0.89612939 |
| 107 | MP0005377_hearing/vestibular/ear_phenot | 0.89612939 |
| 108 | MP0000920_abnormal_myelination | 0.89007180 |
| 109 | MP0001529_abnormal_vocalization | 0.88582263 |
| 110 | MP0000230_abnormal_systemic_arterial | 0.87383151 |
| 111 | MP0000383_abnormal_hair_follicle | 0.86789292 |
| 112 | MP0001346_abnormal_lacrimal_gland | 0.85115166 |
| 113 | MP0005646_abnormal_pituitary_gland | 0.84824467 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.84747595 |
| 115 | MP0003122_maternal_imprinting | 0.84148390 |
| 116 | MP0003941_abnormal_skin_development | 0.83737196 |
| 117 | MP0004133_heterotaxia | 0.83478386 |
| 118 | MP0001293_anophthalmia | 0.83437198 |
| 119 | MP0005386_behavior/neurological_phenoty | 0.82947488 |
| 120 | MP0004924_abnormal_behavior | 0.82947488 |
| 121 | MP0001186_pigmentation_phenotype | 0.80320444 |
| 122 | MP0001440_abnormal_grooming_behavior | 0.79911333 |
| 123 | MP0002066_abnormal_motor_capabilities/c | 0.75981580 |
| 124 | MP0001485_abnormal_pinna_reflex | 0.75192636 |
| 125 | MP0005379_endocrine/exocrine_gland_phen | 0.75144151 |
| 126 | MP0002152_abnormal_brain_morphology | 0.74443263 |
| 127 | MP0001905_abnormal_dopamine_level | 0.72813292 |
| 128 | MP0000678_abnormal_parathyroid_gland | 0.71480393 |
| 129 | MP0005551_abnormal_eye_electrophysiolog | 0.69253888 |
| 130 | MP0002229_neurodegeneration | 0.63889595 |
| 131 | MP0000762_abnormal_tongue_morphology | 0.61667561 |
| 132 | MP0003303_peritoneal_inflammation | 0.61515988 |
| 133 | MP0000490_abnormal_crypts_of | 0.61427170 |
| 134 | MP0004145_abnormal_muscle_electrophysio | 0.61223478 |
| 135 | MP0003718_maternal_effect | 0.61189034 |
| 136 | MP0004811_abnormal_neuron_physiology | 0.59714697 |
| 137 | MP0002163_abnormal_gland_morphology | 0.58815879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 5.58306805 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 5.13174121 |
| 3 | Pancreatic cysts (HP:0001737) | 4.21585843 |
| 4 | Abnormality of midbrain morphology (HP:0002418) | 4.04505643 |
| 5 | Molar tooth sign on MRI (HP:0002419) | 4.04505643 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.01822698 |
| 7 | Congenital stationary night blindness (HP:0007642) | 3.94523046 |
| 8 | Nephronophthisis (HP:0000090) | 3.54524970 |
| 9 | Focal motor seizures (HP:0011153) | 3.43582714 |
| 10 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.40373085 |
| 11 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.40373085 |
| 12 | Abnormal protein glycosylation (HP:0012346) | 3.40373085 |
| 13 | Abnormal glycosylation (HP:0012345) | 3.40373085 |
| 14 | Type II lissencephaly (HP:0007260) | 3.35644084 |
| 15 | Chromsome breakage (HP:0040012) | 3.27624820 |
| 16 | Hyperventilation (HP:0002883) | 3.12515193 |
| 17 | Abnormality of the axillary hair (HP:0100134) | 3.12337604 |
| 18 | Abnormality of secondary sexual hair (HP:0009888) | 3.12337604 |
| 19 | Abnormality of the renal medulla (HP:0100957) | 3.06214443 |
| 20 | Pendular nystagmus (HP:0012043) | 3.03650912 |
| 21 | Abnormal sex determination (HP:0012244) | 3.01440264 |
| 22 | Sex reversal (HP:0012245) | 3.01440264 |
| 23 | Annular pancreas (HP:0001734) | 3.00539519 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 2.98692306 |
| 25 | Chronic hepatic failure (HP:0100626) | 2.91469177 |
| 26 | Cystic liver disease (HP:0006706) | 2.91433809 |
| 27 | Abolished electroretinogram (ERG) (HP:0000550) | 2.91307904 |
| 28 | Medial flaring of the eyebrow (HP:0010747) | 2.89007858 |
| 29 | Decreased circulating renin level (HP:0003351) | 2.86367136 |
| 30 | Septo-optic dysplasia (HP:0100842) | 2.85156365 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.82505987 |
| 32 | Absent/shortened dynein arms (HP:0200106) | 2.82505987 |
| 33 | Febrile seizures (HP:0002373) | 2.77604529 |
| 34 | Thyroid-stimulating hormone excess (HP:0002925) | 2.73511715 |
| 35 | Tubular atrophy (HP:0000092) | 2.70946723 |
| 36 | Duplicated collecting system (HP:0000081) | 2.67136325 |
| 37 | Genetic anticipation (HP:0003743) | 2.64346899 |
| 38 | Congenital, generalized hypertrichosis (HP:0004540) | 2.62592290 |
| 39 | Sclerocornea (HP:0000647) | 2.62229881 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.56584199 |
| 41 | Abnormality of alanine metabolism (HP:0010916) | 2.56584199 |
| 42 | Hyperalaninemia (HP:0003348) | 2.56584199 |
| 43 | Abnormality of the preputium (HP:0100587) | 2.55952404 |
| 44 | Nonprogressive disorder (HP:0003680) | 2.55353426 |
| 45 | Concave nail (HP:0001598) | 2.54486948 |
| 46 | Meckel diverticulum (HP:0002245) | 2.53402756 |
| 47 | Gaze-evoked nystagmus (HP:0000640) | 2.52908002 |
| 48 | Clumsiness (HP:0002312) | 2.52481723 |
| 49 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.50110899 |
| 50 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.49894078 |
| 51 | Hypothermia (HP:0002045) | 2.48776742 |
| 52 | Obstructive sleep apnea (HP:0002870) | 2.48766163 |
| 53 | Supernumerary spleens (HP:0009799) | 2.46429865 |
| 54 | Abnormal drinking behavior (HP:0030082) | 2.45457463 |
| 55 | Polydipsia (HP:0001959) | 2.45457463 |
| 56 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.45419405 |
| 57 | Abnormality of the renal collecting system (HP:0004742) | 2.45414335 |
| 58 | Abnormality of the ileum (HP:0001549) | 2.45378068 |
| 59 | Lissencephaly (HP:0001339) | 2.45255946 |
| 60 | Inability to walk (HP:0002540) | 2.43889129 |
| 61 | Cerebellar dysplasia (HP:0007033) | 2.42541239 |
| 62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.41852247 |
| 63 | Hypoplasia of the pons (HP:0012110) | 2.37350514 |
| 64 | Patellar aplasia (HP:0006443) | 2.36688152 |
| 65 | Optic nerve hypoplasia (HP:0000609) | 2.35983650 |
| 66 | Anencephaly (HP:0002323) | 2.35441755 |
| 67 | Gait imbalance (HP:0002141) | 2.34962597 |
| 68 | Horizontal nystagmus (HP:0000666) | 2.32952723 |
| 69 | Bilateral microphthalmos (HP:0007633) | 2.32617518 |
| 70 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.32517095 |
| 71 | Absent septum pellucidum (HP:0001331) | 2.31617684 |
| 72 | Ocular albinism (HP:0001107) | 2.30529537 |
| 73 | Cortical visual impairment (HP:0100704) | 2.30204024 |
| 74 | Fibular aplasia (HP:0002990) | 2.29610829 |
| 75 | Abnormality of the pons (HP:0007361) | 2.29575729 |
| 76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.28054763 |
| 77 | Attenuation of retinal blood vessels (HP:0007843) | 2.26114941 |
| 78 | Partial agenesis of the corpus callosum (HP:0001338) | 2.24833871 |
| 79 | Clubbing of toes (HP:0100760) | 2.22278681 |
| 80 | Severe visual impairment (HP:0001141) | 2.19860376 |
| 81 | Abnormality of the carotid arteries (HP:0005344) | 2.17683373 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.17657139 |
| 83 | Abnormal ciliary motility (HP:0012262) | 2.17577803 |
| 84 | Fibular hypoplasia (HP:0003038) | 2.16382437 |
| 85 | Parakeratosis (HP:0001036) | 2.16055822 |
| 86 | Chorioretinal atrophy (HP:0000533) | 2.15991663 |
| 87 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.15708281 |
| 88 | True hermaphroditism (HP:0010459) | 2.15190682 |
| 89 | Split foot (HP:0001839) | 2.14870572 |
| 90 | Renal cortical cysts (HP:0000803) | 2.14430689 |
| 91 | Flat occiput (HP:0005469) | 2.12495401 |
| 92 | Duplication of thumb phalanx (HP:0009942) | 2.11391424 |
| 93 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.10104455 |
| 94 | Abnormality of the septum pellucidum (HP:0007375) | 2.09250119 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08327765 |
| 96 | Obstructive lung disease (HP:0006536) | 2.08327765 |
| 97 | Congenital hepatic fibrosis (HP:0002612) | 2.08055637 |
| 98 | Decreased central vision (HP:0007663) | 2.07983921 |
| 99 | Pachygyria (HP:0001302) | 2.06933008 |
| 100 | Progressive cerebellar ataxia (HP:0002073) | 2.06811943 |
| 101 | Broad-based gait (HP:0002136) | 2.06556859 |
| 102 | Retinal dysplasia (HP:0007973) | 2.05915496 |
| 103 | Rib fusion (HP:0000902) | 2.03444449 |
| 104 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.03256552 |
| 105 | Iris hypopigmentation (HP:0007730) | 2.02726172 |
| 106 | Nephrogenic diabetes insipidus (HP:0009806) | 2.02369102 |
| 107 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.01946340 |
| 108 | Hypoplasia of the fovea (HP:0007750) | 2.01946340 |
| 109 | Progressive inability to walk (HP:0002505) | 2.00816355 |
| 110 | Abnormality of magnesium homeostasis (HP:0004921) | 1.99796657 |
| 111 | Keratoconus (HP:0000563) | 1.99758031 |
| 112 | Increased corneal curvature (HP:0100692) | 1.99758031 |
| 113 | Abnormality of the columella (HP:0009929) | 1.99287413 |
| 114 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.98930084 |
| 115 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.98930084 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.98400990 |
| 117 | White forelock (HP:0002211) | 1.98307923 |
| 118 | Reticulocytopenia (HP:0001896) | 1.97462122 |
| 119 | Renal agenesis (HP:0000104) | 1.97113305 |
| 120 | Overriding aorta (HP:0002623) | 1.96935161 |
| 121 | Small hand (HP:0200055) | 1.96760832 |
| 122 | Severe muscular hypotonia (HP:0006829) | 1.96743972 |
| 123 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95978776 |
| 124 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.94056741 |
| 125 | Patchy hypopigmentation of hair (HP:0011365) | 1.92826353 |
| 126 | Large for gestational age (HP:0001520) | 1.90606641 |
| 127 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.88990746 |
| 128 | Polyuria (HP:0000103) | 1.88961530 |
| 129 | Increased CSF lactate (HP:0002490) | 1.87886610 |
| 130 | Focal seizures (HP:0007359) | 1.87555007 |
| 131 | Agitation (HP:0000713) | 1.86673933 |
| 132 | Furrowed tongue (HP:0000221) | 1.86583091 |
| 133 | Abnormality of the prostate (HP:0008775) | 1.85922992 |
| 134 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85733547 |
| 135 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82921760 |
| 136 | Triphalangeal thumb (HP:0001199) | 1.82857144 |
| 137 | Male pseudohermaphroditism (HP:0000037) | 1.82560275 |
| 138 | Flat cornea (HP:0007720) | 1.81176395 |
| 139 | Stomatitis (HP:0010280) | 1.80659646 |
| 140 | Fair hair (HP:0002286) | 1.80538699 |
| 141 | Abnormal number of erythroid precursors (HP:0012131) | 1.80236157 |
| 142 | Genital tract atresia (HP:0001827) | 1.78639573 |
| 143 | Postaxial foot polydactyly (HP:0001830) | 1.78577115 |
| 144 | Bile duct proliferation (HP:0001408) | 1.78498557 |
| 145 | Abnormal biliary tract physiology (HP:0012439) | 1.78498557 |
| 146 | Abnormality of chromosome stability (HP:0003220) | 1.78393686 |
| 147 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.78061351 |
| 148 | Vaginal atresia (HP:0000148) | 1.77412381 |
| 149 | Protruding tongue (HP:0010808) | 1.76757639 |
| 150 | Hepatocellular necrosis (HP:0001404) | 1.76586211 |
| 151 | Birth length less than 3rd percentile (HP:0003561) | 1.76004900 |
| 152 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75867222 |
| 153 | Absent thumb (HP:0009777) | 1.75231515 |
| 154 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.74851709 |
| 155 | Prolonged partial thromboplastin time (HP:0003645) | 1.74708134 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.71526843 |
| 157 | Optic disc pallor (HP:0000543) | 1.71507458 |
| 158 | Pancreatic fibrosis (HP:0100732) | 1.70998819 |
| 159 | Abnormality of DNA repair (HP:0003254) | 1.70227007 |
| 160 | Cutaneous finger syndactyly (HP:0010554) | 1.69226111 |
| 161 | Microvesicular hepatic steatosis (HP:0001414) | 1.67958146 |
| 162 | Acute necrotizing encephalopathy (HP:0006965) | 1.67804102 |
| 163 | Generalized hypopigmentation of hair (HP:0011358) | 1.66966213 |
| 164 | Tented upper lip vermilion (HP:0010804) | 1.66731574 |
| 165 | Hemiparesis (HP:0001269) | 1.66440014 |
| 166 | Thoracic kyphosis (HP:0002942) | 1.65889329 |
| 167 | Occipital encephalocele (HP:0002085) | 1.65879448 |
| 168 | Absent radius (HP:0003974) | 1.65194110 |
| 169 | Sleep apnea (HP:0010535) | 1.64949361 |
| 170 | Progressive external ophthalmoplegia (HP:0000590) | 1.64390226 |
| 171 | Stereotypic behavior (HP:0000733) | 1.63246111 |
| 172 | Abnormal number of incisors (HP:0011064) | 1.63130946 |
| 173 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.61616078 |
| 174 | Dysmetria (HP:0001310) | 1.61144727 |
| 175 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.60528462 |
| 176 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.60445504 |
| 177 | Gastroesophageal reflux (HP:0002020) | 1.60340237 |
| 178 | Embryonal renal neoplasm (HP:0011794) | 1.60062079 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.81930485 |
| 2 | FRK | 5.33514538 |
| 3 | CASK | 4.16727967 |
| 4 | EIF2AK3 | 3.91652791 |
| 5 | MKNK2 | 3.89957935 |
| 6 | CDK19 | 3.49747803 |
| 7 | WNK4 | 2.89202031 |
| 8 | MUSK | 2.69651206 |
| 9 | STK16 | 2.58442835 |
| 10 | MKNK1 | 2.44508198 |
| 11 | WNK3 | 2.26605711 |
| 12 | EIF2AK2 | 2.25024149 |
| 13 | TAOK3 | 2.24301026 |
| 14 | FES | 2.24190719 |
| 15 | MAP2K7 | 2.11479966 |
| 16 | IRAK2 | 2.10042456 |
| 17 | INSRR | 2.04941665 |
| 18 | TLK1 | 2.02735533 |
| 19 | MAP4K2 | 2.01558421 |
| 20 | ACVR1B | 1.95454348 |
| 21 | PRPF4B | 1.83076869 |
| 22 | CAMKK2 | 1.79982299 |
| 23 | SRPK1 | 1.69889234 |
| 24 | NUAK1 | 1.68470802 |
| 25 | CLK1 | 1.59856798 |
| 26 | NLK | 1.58829764 |
| 27 | IRAK1 | 1.54065465 |
| 28 | EPHA4 | 1.53247333 |
| 29 | NTRK3 | 1.52017060 |
| 30 | ADRBK1 | 1.48911760 |
| 31 | DAPK2 | 1.45905609 |
| 32 | IRAK4 | 1.42785653 |
| 33 | PIK3CA | 1.41894930 |
| 34 | YES1 | 1.39293518 |
| 35 | UHMK1 | 1.38092714 |
| 36 | MAPK15 | 1.32745378 |
| 37 | NTRK2 | 1.32142485 |
| 38 | BLK | 1.30853351 |
| 39 | MARK1 | 1.28992311 |
| 40 | OXSR1 | 1.26736140 |
| 41 | MAPK13 | 1.25267488 |
| 42 | IRAK3 | 1.23957487 |
| 43 | NEK6 | 1.18664315 |
| 44 | CSNK1A1L | 1.17517741 |
| 45 | PAK3 | 1.15253351 |
| 46 | CSNK1G3 | 1.09071727 |
| 47 | CSNK1G1 | 1.02535441 |
| 48 | ADRBK2 | 0.96254079 |
| 49 | CAMK1 | 0.94169557 |
| 50 | CAMK1D | 0.93389936 |
| 51 | PRKD2 | 0.90517410 |
| 52 | STK38 | 0.89462272 |
| 53 | TEC | 0.89004684 |
| 54 | TGFBR1 | 0.88733417 |
| 55 | VRK1 | 0.88575444 |
| 56 | BCKDK | 0.88104369 |
| 57 | SIK2 | 0.85081939 |
| 58 | FER | 0.83665011 |
| 59 | PRKCE | 0.82154606 |
| 60 | GRK1 | 0.82084304 |
| 61 | MAP3K12 | 0.81147210 |
| 62 | CSNK1G2 | 0.80976648 |
| 63 | ZAK | 0.79666427 |
| 64 | GRK7 | 0.79261346 |
| 65 | PRKCI | 0.79244329 |
| 66 | RPS6KA6 | 0.79193543 |
| 67 | CAMKK1 | 0.77825900 |
| 68 | MAP3K4 | 0.77301758 |
| 69 | CAMK1G | 0.75930420 |
| 70 | MAP4K1 | 0.70888227 |
| 71 | CHUK | 0.67815778 |
| 72 | TXK | 0.67435827 |
| 73 | MAP3K11 | 0.67239424 |
| 74 | TNK2 | 0.67175838 |
| 75 | PRKCH | 0.67106737 |
| 76 | RPS6KA5 | 0.66847356 |
| 77 | RIPK4 | 0.65162831 |
| 78 | SIK3 | 0.64446390 |
| 79 | PRKACA | 0.64404929 |
| 80 | RPS6KA2 | 0.61717532 |
| 81 | ERBB2 | 0.60829973 |
| 82 | MAP2K6 | 0.59242840 |
| 83 | MAPKAPK5 | 0.58558685 |
| 84 | CDK7 | 0.58427716 |
| 85 | VRK2 | 0.57898292 |
| 86 | STK39 | 0.57820572 |
| 87 | PRKAA1 | 0.57124544 |
| 88 | NME1 | 0.56862600 |
| 89 | MAPKAPK3 | 0.56509859 |
| 90 | MARK2 | 0.56232865 |
| 91 | BRD4 | 0.54492623 |
| 92 | TYRO3 | 0.53379243 |
| 93 | TAF1 | 0.53221848 |
| 94 | CAMK4 | 0.52932304 |
| 95 | NEK2 | 0.50974920 |
| 96 | PKN1 | 0.50471099 |
| 97 | PRKCQ | 0.49689525 |
| 98 | CDK3 | 0.49669599 |
| 99 | PLK4 | 0.49595367 |
| 100 | BMPR1B | 0.49174945 |
| 101 | IKBKB | 0.48687615 |
| 102 | DYRK1A | 0.46447232 |
| 103 | CHEK2 | 0.45233962 |
| 104 | CAMK2A | 0.44895349 |
| 105 | DYRK2 | 0.43935482 |
| 106 | PRKCZ | 0.43857960 |
| 107 | PTK2B | 0.43544519 |
| 108 | CDK5 | 0.43512514 |
| 109 | CAMK2B | 0.42930149 |
| 110 | PRKCA | 0.42216874 |
| 111 | HIPK2 | 0.41801544 |
| 112 | LIMK1 | 0.41530166 |
| 113 | STK38L | 0.40988591 |
| 114 | FGR | 0.40879418 |
| 115 | MAP2K2 | 0.40875336 |
| 116 | DYRK3 | 0.40393114 |
| 117 | TAOK2 | 0.39851495 |
| 118 | BTK | 0.39040596 |
| 119 | AURKA | 0.37274784 |
| 120 | BMPR2 | 0.37089361 |
| 121 | MAP2K4 | 0.35635094 |
| 122 | CSNK1D | 0.35107960 |
| 123 | STK11 | 0.34888355 |
| 124 | PRKG2 | 0.33831967 |
| 125 | PINK1 | 0.33661591 |
| 126 | MAP3K1 | 0.33655631 |
| 127 | LYN | 0.32113476 |
| 128 | KIT | 0.30600522 |
| 129 | PRKCG | 0.30438880 |
| 130 | HCK | 0.29262901 |
| 131 | TIE1 | 0.28328396 |
| 132 | ATR | 0.27815181 |
| 133 | PHKG2 | 0.27696016 |
| 134 | PHKG1 | 0.27696016 |
| 135 | CDC42BPA | 0.27617970 |
| 136 | MAPK10 | 0.23767195 |
| 137 | AKT3 | 0.23757826 |
| 138 | PRKG1 | 0.23701121 |
| 139 | SGK494 | 0.23014271 |
| 140 | SGK223 | 0.23014271 |
| 141 | SGK2 | 0.23011531 |
| 142 | RPS6KB1 | 0.22171510 |
| 143 | CSNK1A1 | 0.22117524 |
| 144 | WNK1 | 0.21639278 |
| 145 | SGK1 | 0.20433944 |
| 146 | CAMK2D | 0.17851850 |
| 147 | EPHB2 | 0.17726663 |
| 148 | FYN | 0.16670990 |
| 149 | PNCK | 0.16370356 |
| 150 | GSK3B | 0.15791101 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.69491756 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.06408396 |
| 3 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.90416343 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.44565026 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32147658 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.16032944 |
| 7 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.13437860 |
| 8 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.11647708 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10611893 |
| 10 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.10146439 |
| 11 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.03076143 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 1.98370314 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.96994515 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 1.96628229 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.96459934 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.87827930 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 1.82581003 |
| 18 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.77719952 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.75184937 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.70809030 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.70249321 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.65410111 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.61554248 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58281934 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.58035344 |
| 26 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.54733147 |
| 27 | GABAergic synapse_Homo sapiens_hsa04727 | 1.54017630 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.52851605 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.52535804 |
| 30 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.45525359 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.41798496 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41767318 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.41318054 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.40403268 |
| 35 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36886415 |
| 36 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.36548891 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.36184167 |
| 38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.35016642 |
| 39 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.34753415 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.33657356 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.23890538 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.23065002 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.18155899 |
| 44 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14802117 |
| 45 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.13370717 |
| 46 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.12404375 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.06855798 |
| 48 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06006274 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.05547528 |
| 50 | Base excision repair_Homo sapiens_hsa03410 | 1.04013224 |
| 51 | Insulin secretion_Homo sapiens_hsa04911 | 1.02749321 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.01779089 |
| 53 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00254161 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96994989 |
| 55 | Spliceosome_Homo sapiens_hsa03040 | 0.94770716 |
| 56 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94321152 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.93237363 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.92659397 |
| 59 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91324962 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91148079 |
| 61 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.90336441 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.90146771 |
| 63 | Protein export_Homo sapiens_hsa03060 | 0.89113494 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.87571066 |
| 65 | Peroxisome_Homo sapiens_hsa04146 | 0.87431923 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85513709 |
| 67 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.84528389 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.84100145 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84016705 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.82992577 |
| 71 | Renin secretion_Homo sapiens_hsa04924 | 0.82509932 |
| 72 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.81552747 |
| 73 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80741876 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78731502 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.78255377 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77350114 |
| 77 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.76808552 |
| 78 | Basal transcription factors_Homo sapiens_hsa03022 | 0.76510843 |
| 79 | Alcoholism_Homo sapiens_hsa05034 | 0.76407264 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.75924452 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75846409 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.74112274 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.72444325 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72430484 |
| 85 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.71474126 |
| 86 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71021597 |
| 87 | Gap junction_Homo sapiens_hsa04540 | 0.70958537 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69764743 |
| 89 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68749069 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66825039 |
| 91 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.64986399 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.64038906 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63389934 |
| 94 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62494119 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61671088 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59930537 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.59468625 |
| 98 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58632867 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58037287 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57986248 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57943761 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57151641 |
| 103 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55169316 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54318888 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.53740526 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.53674985 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53352860 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51921453 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49116856 |
| 110 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48032758 |
| 111 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46113409 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.45906015 |
| 113 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45578530 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45287828 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44698926 |
| 116 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44046403 |
| 117 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43569217 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43495510 |
| 119 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42615478 |
| 120 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42568292 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42377395 |
| 122 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.42352586 |
| 123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42306891 |
| 124 | Asthma_Homo sapiens_hsa05310 | 0.41770957 |
| 125 | Allograft rejection_Homo sapiens_hsa05330 | 0.41357422 |
| 126 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41335357 |
| 127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41100054 |
| 128 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39522339 |
| 129 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39448341 |
| 130 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38107315 |
| 131 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.37414674 |
| 132 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35934951 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35284020 |
| 134 | RNA degradation_Homo sapiens_hsa03018 | 0.33770636 |
| 135 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.33636176 |
| 136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33544271 |
| 137 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.33482824 |
| 138 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33112650 |
| 139 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.32261646 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31222354 |
| 141 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28835304 |

